Overview

A Study on the Effection of Potassium Citrate Extended-release Tablets on Urolithiasis Formation or Recurrence

Status:
Unknown status
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
Assess the efficacy and safety of potassium citrate extended-release tablets on Urolithiasis formation or recurrence.
Phase:
Phase 4
Details
Lead Sponsor:
Dawnrays Pharmaceutical (Holdings) Limited
Treatments:
Citric Acid
Potassium Citrate